AFP and urothelial carcinoma: Serum AFP fluctuation can be used for monitoring the disease course, risk evaluation, and treatment response and can determine clinical outcomes in patients with GC, urothelial carcinoma, childhood NSGCTs, neonatal SCT, NUT midline carcinoma, and APOs.